CANbridge Pharmaceuticals Inc. is a China-focused biopharmaceutical company accelerating development and commercialization of specialty healthcare products for orphan diseases and targeted cancers, focusing on products that are unavailable or address medical needs that are underserved in the region. CANbridge has been recognized as a leader in orphan diseases in China. It has a global partnership with WuXi Biologics to develop and commercialize proprietary therapeutics for the treatment of rare genetic diseases. In greater China, it has an exclusive licensing agreement to commercialize Hunterase®, an enzyme replacement therapy for the treatment of Hunter syndrome, developed by GC Pharma and marketed in more than ten countries worldwide. CANbridge also has an oncology portfolio, which includes exclusive rights to develop and commercialize Puma Biotechnology’s NERLYNX® (neratinib), in greater China, as well as rights to other novel candidates.
View Top Employees from CANbridge Pharmaceuticals Inc.| Website | http://www.canbridgepharma.com |
| Revenue | $3 million |
| Funding | $133 million |
| Employees | 69 (64 on RocketReach) |
| Founded | 2012 |
| Address | 4 Burlington Woods Dr, Burlington, Massachusetts 01803, US |
| Phone | 1084148018 |
| Industry | Biotechnology, Pharmaceutical Manufacturing, Business Services General, Pharmaceuticals, Business Services, Science and Engineering, Health Care, Life Science |
| Web Rank | 17 Million |
| Keywords | Canbridge Pharmaceuticals, Canbridge, China Canbridge Biotech |
| Competitors | Affectis Pharmaceuticals, Aptahem, Dova Pharmaceuticals, Helix Biopharma Corp (HBPCF), Quince Therapeutics |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular CANbridge Pharmaceuticals Inc. employee's phone or email?
CANbridge Pharmaceuticals Inc. Questions
The CANbridge Pharmaceuticals Inc. annual revenue was $3 million in 2024.
Jun Yang is the Vice President of Non-Clinical Development of CANbridge Pharmaceuticals Inc..
64 people are employed at CANbridge Pharmaceuticals Inc..
CANbridge Pharmaceuticals Inc. is based in Burlington, Massachusetts.
The NAICS codes for CANbridge Pharmaceuticals Inc. are [3254, 325, 32, 32541].
The SIC codes for CANbridge Pharmaceuticals Inc. are [283, 28].
Top CANbridge Pharmaceuticals Inc. Employees
Related Companies
